Clindamycin 300mg capsules

Valsts: Lielbritānija

Valoda: angļu

Klimata pārmaiņas: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktīvā sastāvdaļa:

Clindamycin hydrochloride

Pieejams no:

Accord-UK Ltd

ATĶ kods:

J01FF01

SNN (starptautisko nepatentēto nosaukumu):

Clindamycin hydrochloride

Deva:

300mg

Zāļu forma:

Oral capsule

Ievadīšanas:

Oral

Klase:

No Controlled Drug Status

Receptes veids:

Valid as a prescribable product

Produktu pārskats:

BNF: 05010600

Lietošanas instrukcija

CLINDAMYCIN 150MG AND 300MG
HARD CAPSULES
Clindamycin hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
READ ALL OF THIS LEAFLET CAREFULLY BEFORE
YOU START TAKING THIS MEDICINE BECAUSE IT
CONTAINS IMPORTANT INFORMATION FOR YOU.
• Keep this leaflet. You may need to read it
again.
• If you have any further questions, ask your
doctor, pharmacist or nurse.
• This medicine has been prescribed for you
only. Do not pass it on to others. It may
harm them, even if their signs of illness are
the same as yours.
• If you get any side effects, talk to your
doctor, pharmacist or nurse. This includes
any possible side effects not listed in this
leaflet. See section 4.
• The full name of this medicine is
Clindamycin 150mg, 300mg Hard
Capsules but within the leaflet it will be
referred to as Clindamycin.
WHAT IS IN THIS LEAFLET
1 WHAT CLINDAMYCIN IS AND WHAT IT IS
USED FOR
2 WHAT YOU NEED TO KNOW BEFORE YOU
TAKE CLINDAMYCIN
3 HOW TO TAKE CLINDAMYCIN
4 POSSIBLE SIDE EFFECTS
5 HOW TO STORE CLINDAMYCIN
6 CONTENTS OF THE PACK AND OTHER
INFORMATION
1 WHAT CLINDAMYCIN IS AND WHAT IT IS
USED FOR
Clindamycin_ _Capsules contain clindamycin
which is an antibiotic used in the treatment of
severe bacterial infections.
2 WHAT YOU NEED TO KNOW BEFORE YOU
TAKE CLINDAMYCIN
DO NOT TAKE CLINDAMYCIN
• if you are allergic to clindamycin, lincomycin
or to any of the ingredients of this medicine
(listed in section 6).
• if you have diarrhoea.
WARNINGS AND PRECAUTIONS
Talk to your doctor, pharmacist or nurse before
taking Clindamycin Tell your doctor if:
• you usually get diarrhoea when you take
antibiotics or have ever suffered from
problems with your stomach or intestines. If
you develop severe or prolonged or bloody
diarrhoea during or after using Clindamycin
TELL YOUR DOCTOR IMMEDIATELY since it may
be necessary to interrupt the treatment.
This may be a sign of bowel inflammation
(pseudomembranous colitis) which can occur
following treatment with antibiotics.
• you suffer from problems with your kidneys
or liver. If you h

Produkta apraksts

OBJECT 1
CLINDAMYCIN 300MG HARD CAPSULES
Summary of Product Characteristics Updated 04-Aug-2016 | Accord-UK Ltd
1. Name of the medicinal product
Clindamycin 300mg Hard Capsules
2. Qualitative and quantitative composition
Each capsule contains 325.78 mg clindamycin hydrochloride equivalent
to 300 mg clindamycin.
Excipient with known effect:
Each capsule contains 67.82 mg anhydrous lactose (see section 4.4).
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Hard capsule
Size '0' hard gelatin capsule with opaque white cap and opaque white
body imprinted with 'A718' on cap
with black ink.
4. Clinical particulars
4.1 Therapeutic indications
Clindamycin is indicated for the treatment of severe infections (see
sections 4.4 and 5.1).
Consideration should be given to official guidance on the appropriate
use of antibacterial agents.
4.2 Posology and method of administration
Posology
_Adults_
Moderately severe infection: 150 - 300 mg every six hours
Severe infection: 1200 - 1800 mg daily in divided doses given every
six to eight hours
_Elderly_
The half-life, volume of distribution and clearance, and extent of
absorption after administration of
clindamycin hydrochloride are not altered by increased age. Analysis
of data from clinical studies has not
revealed any age-related increase in toxicity. Dosage requirements in
elderly patients, therefore, should
not be influenced by age alone.
_Children:_ 3 - 6 mg/kg every six hours depending on the severity of
the infection.
Clindamycin capsules are not suitable for children who are unable to
swallow them whole. The capsules
do not provide exact mg/kg doses therefore it may be necessary to use
an alternative formulation in some
cases.
_Renal impairment_
No dose adjustment is necessary in patients with mild to moderate
impairment of renal function. In
patients with severe renal impairment or anuria, plasma concentration
should be monitored. Depending on
the results, this measure can make a reduction in dosage or an
increase in the dose interval of 8 or even 12